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Kristen L. Curran and Robert M. Grainger1
Department of Biology, University of Virginia, Charlottesville, Virginia 22903
FGF signaling has been implicated in germ layer formation and axial determination. An antibody specific for the activated
form of mitogen-activated protein kinase (MAPK) was used to monitor FGF signaling in vivo during early Xenopus
development. Activation of MAPK in young embryos is abolished by injection of a dominant negative FGF receptor (XFD)
RNA, suggesting that MAPK is activated primarily by FGF in this context. A transition from cytoplasmic to nuclear
localization of activated MAPK occurs in morula/blastula stage embryo animal and marginal zones coinciding with the
proposed onset of mesodermal competence. Activated MAPK delineates the region of the dorsal marginal zone before
blastopore formation and persists in this region during gastrulation, indicating an early role for FGF signaling in dorsal
mesoderm. Activated MAPK was also found in posterior neural tissue from late gastrulation onward. Inhibition of FGF
signaling does not block posterior neural gene expression (HoxB9) or activation of MAPK; however, inhibition of FGF
signaling does cause a statistically significant decrease in the level of activated MAPK. These results point toward the
involvement of other receptor tyrosine kinase signaling pathways in posterior neural patterning. © 2000 Academic Press
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While many FGF family members have been implicated
in mesoderm formation and axial patterning in the verte-
brate embryo, it is not clearly established whether FGFs are
required for the initial induction of mesoderm in vivo. Early
n vitro experiments defined FGF as a ventroposterior
esoderm inducer, although the expression pattern of FGFs
dentified to date does not fit with this model (Slack et al.,
988; Ruiz i Altalba and Melton, 1989; Green et al., 1990;
ho and De Robertis, 1990). In Xenopus, eFGF, FGF3,
GF9, and FGF receptor 1 (FGFR1) are expressed in the
nimal cap and marginal zone of blastula stage embryos and
round the blastopore during gastrulation. These FGF sig-
aling components are expressed in cells responding to
esodermal induction, not in cells inducing mesoderm,
hich are found at the vegetal pole of the embryo (reviewed
n Slack, 1996; Isaacs, 1997). FGF signaling may be required
1 To whom correspondence should be addressed at the Depart-
ment of Biology, Gilmer Hall, University of Virginia, Charlottes-
ville, VA 22903. Fax: (804) 982-5626. E-mail: rmg9p@virginia.edu.
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All rights of reproduction in any form reserved.or the mesodermal induction process to occur in respond-
ng cells. The low level of FGF found in the blastula stage
arginal zone has been implicated in the ability (compe-
ence) of this tissue to respond to mesodermal induction
Cornell et al., 1995).
FGF signaling has been shown to be necessary at some
tage in mesoderm induction or patterning since this path-
ay is essential for the proper formation of most mesoder-
al tissues. Embryos injected with RNA encoding a domi-
ant negative form of the FGF receptor (XFD) show
eficiencies in muscle and notochord and severe truncation
f posterior structures (Amaya et al., 1991, 1993). Some of
hese phenotypes might be due to inhibition of gastrulation
ovements, which is also seen in fgfr-1 mouse knockouts
Yamaguchi et al., 1994; Deng et al., 1994). Transgenic
mbryos which do not begin expressing XFD until late
lastula stages were unable to maintain mesoderm which
ad been induced before FGF signaling was eliminated
Kroll and Amaya, 1996). These and other studies indicate
hat FGF signaling is responsible in part for the proper
esponse to and maintenance of mesodermal induction.The formation and maintenance of mesoderm in Xenopus
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42 Curran and Graingerhas been shown to require FGF signaling within developing
mesoderm through a regulatory loop involving the T-box
transcription factor, Xbrachyury (Xbra). Evidence provided
by Schulte-Merker and Smith (1995) and Slack et al. (1996)
indicates that mesoderm formation requires an intact FGF
signaling pathway downstream of Xbra, in which Xbra
activates expression of FGF which then aids in the mainte-
nance of Xbra expression. This may explain why the
phenotypes of XFD-injected embryos resemble that of em-
bryos mutant for Xbra (Schulte-Merker and Smith, 1995).
A number of questions remain regarding the later role of
FGF during neural induction and patterning. bFGF has been
shown to induce a neuronal fate in dissociated animal cap
cells and in animal caps held open in a low calcium/
magnesium solution (Kengaku and Okamoto, 1993; Lamb
and Harland, 1995) as well as in intact animal caps (Barnett
et al., 1998). Results from Launay et al. (1996) indicate that
inhibition of FGF signaling can block neural induction. On
the other hand, Harland (1997) describes an experiment
indicating that FGF signaling is not required in vivo for
neural induction. FGF has been argued to play a key role in
development of posterior neural character (Isaacs et al.,
1994; Cox and Hemmati-Brivanlou, 1995; Sasai and De-
Robertis, 1996; Pownall et al., 1996). As mentioned earlier,
XFD RNA causes posterior truncations in injected embryos
(Amaya et al., 1991, 1993). Holowacz and Sokol (1999) have
reported that XFD-expressing ectoderm is not induced to
express the posterior neural marker, HoxB9, consistent
with the view that FGF is required for posterior patterning.
However, Kroll and Amaya (1996) found that HoxB9 is
present in transgenic embryos expressing XFD, suggesting
that FGF signaling does not play a major role in posterior
neural patterning in vivo.
If one could monitor the response of cells to growth
factors such as FGF in the embryo, one might then better
understand where, when, and how these pathways influ-
ence mesoderm formation and dorsoaxial patterning of
tissues during development. Gabay et al. (1997a) developed
an antibody that recognizes the dually phosphorylated
(activated) forms of MAPK (p42 and p44), which is very
useful in this regard in Xenopus. Gabay and colleagues
(1997b) were able to use this antibody in Drosophila to
evaluate activation of MAPK by both EGF and FGF receptor
pathways. As we show here, and as reported by Christen
and Slack (1999), this antibody serves as a very useful
indicator of FGF signaling in Xenopus laevis. While MAPK
is potentially a target of many receptor tyrosine kinases
(RTKs) (reviewed by Ferrell, 1996; Lewis et al., 1998),
activation of p42 MAPK in young Xenopus embryos is at
least in large part associated with only FGF signaling
(LaBonne et al., 1995).
We find that the early expression of the activated MAPK
in Xenopus embryos is cytoplasmic and becomes increas-
ingly nuclear during blastula stages during a window of
time when mesodermal competence is first activated. High
levels of activated MAPK are then seen in the area prior to
dorsal lip formation, indicating a very early response to FGF
Copyright © 2000 by Academic Press. All rightsignaling in the dorsal mesoderm. Finally, our assays for
inhibiting FGF signaling argue that this pathway is not
required for posterior neural patterning or expression of
activated MAPK in posterior neural tissue, although inhi-
bition of FGF signaling does somewhat reduce the level of
activated MAPK in this tissue. Therefore, it is possible that
FGF acts in concert with other RTK signaling pathways to
pattern the posterior neural tissue or that other RTK
signaling pathways alone pattern posterior neural tissue.
MATERIALS AND METHODS
Obtaining embryos. An albino strain of X. laevis (Xenopus I)
as used for all experiments. Embryos were collected from females
njected with 800 units of human chorionic gonadotropin (Provet).
fter 12 h eggs were laid and fertilized with macerated testis.
mbryos were then maintained in a low ionic strength salt solution
uch as 110 3 normal amphibian medium (Slack, 1984) or
1
3 3
modified Barth’s solution (MBS; Peng, 1991). All embryo stages
were determined according to Nieuwkoop and Faber (1994).
Embryo manipulation and culture. Two-cell stage embryos
were normally injected with 4 ng of RNA (2 ng per blastomere) of
d50/Xss RNA (inactive FGF receptor) or XFD RNA (dominant
negative FGF receptor) (Amaya et al., 1991). Occasionally, higher
levels of RNA were injected (6 and 8 ng), e.g., for the dose–response
study shown in Table 1. Three hundred picograms of
b-galactosidase (b-gal) RNA was co-injected with 4 ng of XFD RNA
or use as a lineage label to identify XFD-expressing cells (Amaya et
l., 1993). Embryos were injected in a solution of 13 MBS contain-
ng 3.0% w/v Ficoll (Sive et al., 2000) and maintained after
njection in 13 3 MBS. Lineage labeling was used to identify tissues
formed in recombinants between ectoderm from RNA-injected
embryos and mesoderm from untreated embryos. This was accom-
plished by injecting one-cell embryos with 10 nl of 50 mg/ml
rhodamine-labeled dextran amine (RLDX; Molecular Probes, de-
scribed by Gimlich and Braun, 1985). Recombinants made between
RNA-injected animal cap ectoderm and lineage-labeled dorsal
mesoderm were first cultured in 13 MBS and, after healing, moved
to 1⁄23 MBS until the appropriate stage of development.
Animal caps were isolated from blastula stage embryos for
testing the efficacy of XFD RNA in inhibiting FGF signaling.
Animal cap tissue was cultured in 1⁄23 MBS, 0.1% BSA either with
or without 50 ng/ml human recombinant bFGF (Gibco BRL, No.
13256-029). Sensorial ectoderm was isolated by peeling off the
outer layer of ectoderm from the animal cap region of late blastula
stage (stage 9) embryos and subsequently removing the inner
sensorial layer with an eyebrow hair tool. The isolated sensorial
ectoderm was cultured in a modified version of Danilchik’s me-
dium (Peng, 1991) with or without bFGF.
In vitro transcription of RNA for injection. d50/Xss and XFD
clones were kindly provided by Enrique Amaya (The Wellcome/
CRC Institute, Cambridge, UK). Both clones were linearized with
EcoRI and transcribed with SP6 RNA polymerase according to the
procedure of Green et al. (1983). b-Gal in the plasmid vector pCS2
as kindly provided by Ralph Rupp (Max Planck Gesellschaft,
ubingen, Germany). It was linearized with NotI and transcribed
ith SP6 RNA polymerase. RNA levels were quantified using UV
pectrophotometry and gel electrophoresis.
b-Galactosidase staining. Embryos and recombinants express-ing XFD and b-gal were fixed [2% formaldehyde, 0.2% glutaralde-
s of reproduction in any form reserved.
t
1
43MAP Kinase in Early Xenopus Developmenthyde, 0.02% NP-40, and 0.01% deoxycholate dissolved in 13
phosphate-buffered saline (PBS)] for 45 min on ice. Staining was
performed as described by Amaya et al. (1993). Further analysis was
performed using whole-mount immunohistochemistry.
Whole-mount immunohistochemistry. Embryos were demem-
branated and fixed in MEMFA (Harland, 1991) for 45 min to 1 h.
The protocol for antibody staining was based on the procedure of
Brivanlou and Harland (1989). The primary antibody, monoclonal
anti-MAP kinase, activated (Sigma M8159), was used at a dilution
of 1:100 and the secondary antibody, peroxidase-conjugated goat
anti-mouse IgG (H1L), was used at a 1:500 dilution (Jackson
Immunological Laboratory). NiCl (0.5%) was added to enhance the
peroxidase color reaction. After the color reaction was complete,
the samples were washed twice in PBS (Sambrook et al., 1989) and
fixed overnight at 4°C in MEMFA for further analysis (histology
and photography). For unexplained reasons we found that the
sensitivity of the antibody was variable between experiments. The
data for all figures and tables in this paper were taken only from
experiments in which the antibody sensitivity was considered
optimal. Data for each figure or table were collected from three
independent experiments.
Western blotting. Blastula stage (stage 9) embryos were fixed
overnight in Dents fixative (20% DMSO, 80% MeOH) at 220°C
and later dissected into animal poles, marginal zones, and vegetal
poles. Fixation was done to avoid activation of MAPK by wound-
ing. The protocol was performed essentially as described by La-
Bonne and Whitman (1997) except that the tissue was sonicated in
10 ml of NP-40 buffer containing protease and phosphatase inhibi-
ors [0.5% NP-40, 20% (v/v) glycerol, 50 mM Tris–HCl (pH 7.5),
50 mM NaCl, 1 mM DTT, 0.05 mg/ml PMSF, 100 mM Na-b-
glycerophosphate, 1 mM Na-orthovanadate, 1 mM Na-molybdate].
Also, 1 ml of each sample was used for the standard Bradford assay
(Bio-Rad) to determine the concentration of protein within each
sample. The primary antibody [anti-MAP kinase, activated (Sigma)]
was used at a 1:500 dilution and the secondary antibody
[peroxidase-conjugated goat anti-mouse IgG (H1L) (Jackson Immu-
nological Laboratory)] was used at a 1:3000 dilution.
In situ hybridization. In situ hybridization was carried out
according to the procedure of Harland (1991) as modified by
Doniach and Musci (1995). The Xbra probe (Smith et al., 1991) was
made by cutting plasmid DNA with SspI and transcribing the insert
with T7 RNA polymerase. HoxB9 (Sharpe and Gurdon, 1990) probe
was made by cutting plasmid DNA with SmaI and transcribing the
insert with T7 RNA polymerase.
Histology and photography. Following whole-mount immu-
nohistochemistry or in situ hybridization, embryos were examined
as whole mounts in PBS or cleared in benzyl benzoate:benzyl
alcohol, 2:1. Some embryos were embedded in paraffin and sec-
tioned at 10 mm. Sections were mounted in Permount. Whole
mounts were photographed on an Olympus SZH10 research stereo-
scope with an Olympus PM-C35DX camera. Sectioned and cleared
samples were photographed on a Zeiss Axioskop microscope.
RESULTS
Activation of MAPK during Early Embryonic
Development Requires FGF Signaling
Before using the antibody described by Gabay et al.
(1997a) for studies in Xenopus, we confirmed that it recog-
nizes Xenopus MAPK. LaBonne and Whitman (1994) iden-
tified Xenopus MAPK as a 42-kDa protein by Western blot
Copyright © 2000 by Academic Press. All rightanalysis. Western blot analysis performed with the acti-
vated MAPK antibody on blastula and gastrula stage ecto-
derm induced with FGF yields a single band that migrates at
about 42 kDa. No reaction with the antibody was detected
in an equal amount of untreated ectoderm (data not shown).
As will be described in detail below, activated MAPK is
found in a number of tissues in young embryos, for ex-
ample, encircling the blastopore of gastrula stage embryos
(Fig. 1A). To examine the extent to which activated MAPK
in embryos is a result of FGF signaling, two-cell stage
embryos were injected with 4, 6, or 8 ng of RNA encoding
a dominant negative FGF receptor (XFD) or an inactive form
of the FGF receptor (d50/Xss) (Amaya et al., 1991). Embryos
were then fixed at the midgastrula stage (stage 10.5/11) and
analyzed for expression of the mesodermal regulatory gene
Xbra (by whole-mount in situ hybridization) and for acti-
vated MAPK (by whole-mount immunostaining). The ex-
pression of Xbra in XFD-injected embryos was used as a
control for the effectiveness of the dominant negative FGF
receptor, since maintenance of Xbra expression is known to
require FGF signaling (Smith et al., 1991; Amaya et al.,
1993).
Xbra expression was either undetectable (in 12% of
injected embryos; Fig. 1D, Table 1) or greatly reduced (in
80% of injected embryos; Fig. 1F, Table 1) in embryos
injected with XFD RNA. Xbra expression was defined as
greatly reduced in cases in which expression was less than
two-thirds of the way around the blastopore at midgastrula
stages (stage 10.5/11). In many of these embryos Xbra
expression was reduced to a very small patch of tissue.
Amaya et al. (1993) observed similar expression patterns of
Xbra in embryos injected with XFD RNA. They noted that
they were unable to uniformly express the RNA throughout
the embryo. Normal expression of Xbra was seen in em-
bryos injected with the control construct d50/Xss (in 100%
of injected embryos; Fig. 1B, Table 1).
Activated MAPK was similarly decreased with injection
of XFD RNA. The pattern of activated MAPK around the
blastopore was greatly reduced (in 90% of the cases; Fig. 1E,
Table1) in XFD-injected embryos. The pattern ranged again
from a very small domain of activated MAPK to interrup-
tion of the pattern in only one quadrant of the blastopore.
Total ablation of detectable activated MAPK expression
was rare (in 2% of cases; Fig. 1C, Table1). The levels of
activated MAPK in the animal cap ectoderm of XFD-
injected embryos were also either absent or reduced as well
(data not shown). We observed that activated MAPK expres-
sion is more readily ablated from the ventral and lateral
parts of the embryo, although it is possible to eliminate
dorsal expression (Figs. 1C and 1E; arrowhead denotes
ventral expression of activated MAPK with absence in the
dorsal region). High levels of eFGF (Isaacs et al., 1995) and of
MAPK activity (as described below and in LaBonne et al.,
1995) in the dorsal marginal zone may explain why it is
difficult to suppress fully the expression of Xbra or acti-
vated MAPK in this region of the embryo with XFD.The efficacy of dominant negative FGF receptor was also
s of reproduction in any form reserved.
expression as well (I). Scale bar, 225 mm.
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Copyright © 2000 by Academic Press. All righttested by evaluating its ability to block MAPK activation in
FGF-treated ectoderm. Ectoderm was incubated with FGF
(50 ng/ml) for 5 min, which is sufficient to detect the
activation of MAPK by FGF (Graves et al., 1994; LaBonne et
al., 1995). In fact, we can detect activated MAPK in ecto-
derm treated with as little as 2 ng/ml FGF after 5 min (data
not shown). In this experiment the inner, or sensorial, layer
of the animal cap ectoderm was removed from late blastula
stage embryos (stage 9) and cultured to gastrula stages (stage
10.5/11) before treatment. The culturing was done to cir-
cumvent the transient activation of MAPK by wounding
(LaBonne and Whitman, 1997; Christen and Slack, 1999).
Sensorial ectoderm was used because activated MAPK is
present at high enough levels in untreated outer ectoderm
to complicate interpretation of the effect of FGF treatment.
Uninjected sensorial ectoderm showed a strong activation
of MAPK in response to FGF (Fig. 1G; Table 2) while
ectoderm taken from embryos injected with XFD RNA (4
ng) was in most cases predominantly negative for activated
MAPK. Though inhibition of MAPK activity by XFD is
clear, a few cases showed no discernable inhibition (“11”
category in Table 2) and most cases still have a small
fraction (less than 20%) of cells that are positive for acti-
vated MAPK (Fig. 1H; “1/2” category in Table 2). Incom-
plete inhibition of MAPK activity is likely to be the result
of mosaic expression of XFD RNA in the embryo. No
activated MAPK was detected in sensorial ectoderm cul-
tured alone (Fig. 1I; Table 2). There is a low level of
activated MAPK in the inner layer of whole embryos (e.g.,
Fig. 2E) which seems to be lost or greatly reduced in
explanted sensorial ectoderm. Inhibition of activated
MAPK expression in XFD-expressing sensorial ectoderm
treated with FGF provides further evidence that injected
XFD mRNA results in a substantial inhibition of FGF
signaling in the whole embryo and that activation of MAPK
is directly affected by FGF signaling.
Given the evidence outlined above, we conclude that the
FGF pathway is at least largely responsible for activated
MAPK activity during early gastrulation. Consequently, the
expression of activated MAPK in early Xenopus embryos is
a useful marker of active FGF signaling during early devel-
opment.
A Cytoplasmic-to-Nuclear Transition of Activated
MAPK Can Be Detected in the Animal Cap during
Blastula Stages
We were interested in looking at the expression of acti-
vated MAPK during morula and blastula stages of develop-
ment because of the possibility that it might be activated
during the time when mesodermal competence is acquired.
Jones and Woodland (1987) have shown that the ability of
the animal cap to respond to mesodermal induction (com-
petence) begins around stage 6.5. During morula stages of
Xenopus development (stage 6), activated MAPK is ob-
served predominantly in the cytoplasm of the animal capFIG. 1. Embryos injected with 4 ng of an inactive form of the
FGF receptor RNA (d50/Xss) (A and B) or 4 ng of the dominant
negative form of the FGF receptor RNA (XFD) (C–F). All embryos
are oriented with the dorsal side of the blastopore toward the
top. Immunostaining by anti-MAP kinase, activated, was ob-
served to encircle the blastopore of stage 10.5/11 control em-
bryos (A) but staining was absent (C) or greatly reduced (E) in
embryos injected with XFD. Similar results were observed with
Xbra in situ hybridization. Normal Xbra expression was ob-
served in embryos injected with d50/Xss (B) but staining was
either absent (D) or greatly reduced (F) in embryos injected with
XFD. Sensorial ectoderm of animal caps was treated for 5 min
with 50 ng/ml FGF. Uninjected ectoderm showed activated
MAPK expression (G, see arrows) while those injected with XFD
showed mosaic expression in which less then 20% of the cells
were positive for activated MAPK (H, arrows) or showed no
expression (H). Ectoderm not treated with FGF showed noand marginal zone (Fig. 2A, see inset). These regions have
s of reproduction in any form reserved.
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45MAP Kinase in Early Xenopus Developmentbeen fate-mapped to contain the prospective ectoderm and
mesoderm of the embryo (Bauer et al., 1994). No staining is
een in the vegetal pole (data not shown). The highly
ytoplasmic localization of activated MAPK was unex-
ected since growth factor-activated MAPK is found in the
ucleus where it can then influence downstream transcrip-
ion (reviewed by Ferrel, 1996). Lenormand et al. (1993)
showed, however, that MAPK is first activated in the
cytoplasm by MAPK kinase and then translocates to the
nucleus. At stage 7 we begin to see localization of activated
MAPK in nuclei (Fig. 2B, see inset).
During blastula stages, activated MAPK was observed in
the animal cap and marginal zone of the embryo, but was
not detected in the vegetal pole. During mid- to late
TABLE 1
Effect of Dominant Negative FGF Receptor (XFD) RNA Injection o
and Activated MAPK Protein in Midgastrula Embryos
RNA injected
Normal expression
Xbra
RNA
MAPK
protein
ontrol (d50/Xss)
4 ng 12/12 12/12
6 ng 6/6 6/6
8 ng 5/5 7/7
Total 23/23 25/25
(100%) (100%)
ominant negative (XFD)
4 ng 4/30 2/31
6 ng 0/11 2/10
8 ng 0/9 0/9
Total 4/50 4/50
(8%) (8%)
Note. Normal expression refers to periblastoporal expression of
in stage 10.5/11 albino embryos. Greatly reduced expression refers
around two-thirds of the circumference of the embryo. Expressi
activated MAPK or Xbra.
TABLE 2
Effect of Dominant Negative FGF Receptor (XFD) RNA Injection o
in Isolated Ectoderm Treated with FGF
Ac
11 1
Ectoderm 1 FGF 17 4
XFD-expressing ectoderm 1 FGF 3 0
Untreated ectoderm 0 0
Note. Sensorial ectoderm taken from animal caps of stage 10.5/1
ng/ml bFGF for 5 min. 11 denotes strong level of expression in
negative ectoderm with less than 20% positively staining cells (mosaic
Copyright © 2000 by Academic Press. All rightlastula stages the level of activated MAPK appears to
ncrease in nuclei (Figs. 2B and 2C). By late blastula stages
stage 9), activated MAPK is clearly observed in nuclei in
oth the outer and the inner layers of the animal cap and
arginal zone in whole-mount-immunostained embryos
nd embryos sectioned after immunostaining (Figs. 2D and
E). As at earlier stages, activated MAPK is not detected in
egetal cells. LaBonne and Whitman (1997) reported that
tage 9 animal cap ectoderm had the lowest levels of MAPK
ctivity compared to explants of the marginal zone and
egetal pole. It is possible, however, that we did not detect
ctivated MAPK in the vegetal pole in our assay because of
problem with penetration of the antibody through the
olky vegetal cells. This has been noted as a problem for
pression of Xbra RNA
Greatly reduced
expression Expression not detected
Xbra
RNA
MAPK
protein
Xbra
RNA
MAPK
protein
0/12 0/12 0/12 0/12
0/6 0/6 0/6 0/6
0/5 0/7 0/5 0/7
0/23 0/25 0/23 0/25
(0%) (0%) (0%) (0%)
25/30 28/31 1/30 1/31
9/11 8/10 2/11 0/10
6/9 9/9 3/9 0/9
40/50 45/50 6/50 1/50
(80%) (90%) (12%) (2%)
activated MAPK antibody staining and Xbra in situ hybridization
e loss of the periblastoporal pattern of activated MAPK or Xbra in
t detected refers to embryos with no discernable expression of
e Expression of Activated MAPK
ed MAPK expression
Total positive1/2 (mosaic) 2
0 0 21/21 (100%)
20 1 3/24 (12.5%)
0 6 0/6 (0%)
bryos was used for all experiments. Ectoderm was treated with 50
cell, 1 denotes expression in every cell, 1/2 denotes primarilyn Ex
both
to th
on non th
tivat
1 em
every), and 2 denotes nonexpressing ectoderm.
s of reproduction in any form reserved.
46 Curran and Graingerwhole-mount in situ hybridization (Frank and Harland,
1992; Lemaire and Gurdon, 1994) and for whole-mount
immunostaining (K. Mowry, personal communication). We
could detect activated MAPK protein in vegetal pole ex-
plants analyzed by Western blot using the activated MAPK
antibody (data not shown). However, when equal amounts
of protein from stage 9 animal cap, marginal zone, and
vegetal pole were analyzed, more activated MAPK protein
was detected in the animal cap and marginal zone (Fig. 2F).
It is known that FGF is present in the animal cap and
marginal zone during blastula stages (reviewed by Slack,
1996; Isaacs, 1997); the data presented here suggest that
FGF signaling is activating MAPK during early blastula
stages in the animal cap and marginal zone.
An Increase in Activated MAPK Was Observed in
the Mesoderm of Late Blastula and Gastrula Stage
Embryos
During late blastula and gastrula stages, a substantial
increase in the level of activated MAPK is seen in the
mesoderm. In late blastula (stage 9) embryos an increase in
activated MAPK is first observed in what will be the
involuting marginal zone of the dorsal lip of the blastopore
(Figs. 2G and 2H, see insets). During gastrulation, activated
MAPK is seen strongly in mesodermal cells prior to their
involution around the blastopore lip. This expression is first
seen in the dorsal part of the blastopore, then subsequently
around the entire blastopore concurrent with the formation
of the ventral lip (Figs. 1A and 3A). This is consistent with
studies showing that MAPK is activated during mesoder-
mal induction (Hartley et al., 1994; LaBonne and Whitman,
1994; Gotoh et al., 1995). The periblastoporal pattern of
activated MAPK during gastrulation coincides with eFGF
and Xbra RNA expression (Slack et al., 1996; Isaacs, 1997).
Activated MAPK is seen in both the outer and the inner
layers of the involuting zone, but as the tissue continues to
move anteriorly along the blastopore roof activated MAPK
is lost (Fig. 3B). Similar downregulation of eFGF as well as
Xbra has been observed in equivalent postinvolution me-
soderm (Slack et al., 1996).
FIG. 2. Activated MAPK expression becomes localized to the
nucleus of the animal cap during blastula stages and later is
observed to increase dorsally. (A–C) Animal views of cleared
embryos at stage 6 (A), stage 7 (B), and stage 8 (C) (magnified in
insets). Nuclear staining was observed to increase between stages 6
and 7 (see insets). By stage 9 (D) staining was observed in the animal
cap (ac) and marginal zone (mz), but not in the vegetal pole (vp). (E)
A sagittal section through a stage 9 embryo. Equal amounts of ac,
mz, and vp protein were analyzed by Western blot using the
activated MAPK antibody (F). Activated MAPK was detected in the
ac and mz, but not in the vp. An increase in activated MAPK
expression was observed prior to dorsal lip formation (G, magnified
in inset). (H) A sagittal section of the embryo pictured in G, dorsal
staining is magnified in the inset. Scale bar, 350 mm.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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47MAP Kinase in Early Xenopus DevelopmentDuring Neurulation MAPK Activity in Posterior
Mesodermal Tissue, but Not in Posterior Neural
Tissue, Depends on FGF Signaling
As gastrulation progresses, activated MAPK is found
around the blastopore in involuting mesoderm and in what
will become posterior neural tissue (arrows in Figs. 3A and
3B). During early neurula stages and into tail bud stages,
activated MAPK can be seen at high levels in the posterior,
decreasing anteriorly (Fig. 3C). In section, staining is found
in the posterior mesoderm and neural tissue (Fig. 3D).
Sectioning of neurula stage embryos also shows that acti-
vated MAPK is found in more lateral regions of the poste-
rior neural tissue that are not underlain by mesoderm
expressing activated MAPK or Xbra (data not shown). This
pattern of activated MAPK in posterior neural tissue is
highlighted in whole-mount-stained embryos by an arrow
in Fig. 3C and by arrowheads in Fig. 4E. For comparison, a
FIG. 3. Increased activated MAPK expression was observed to c
rrowhead indicates dorsal). (B) A sagittal section of staining in a
pecifically, increased staining occurs in the presumptive mesode
nvoluted mesoderm (im) and is not present in the anterior neural
hown here in C and D) activated MAPK expression remains loca
nterior on the right and posterior to the left. In a sagittal section
een in the posterior mesoderm (pm, notochord) and neural (pn) tisimilar region in an Xbra-stained embryo (arrowheads in w
Copyright © 2000 by Academic Press. All rightig. 4I) does not reveal Xbra expression in underlying lateral
esoderm. If FGF signaling is required for this more lateral
APK activity, it must then be generated within the neural
issue. This observation is of interest since it is thought
hat FGF signaling from the underlying mesoderm acts to
osteriorize neural tissue (e.g., Cox and Hemmati-
rivanlou, 1995). This result then also raises the possibility
hat activated MAPK in lateral regions of posterior neural
issue is due to signaling through another RTK pathway.
To test whether activated MAPK present in the posterior
eural tissue is due to FGF signaling, we first examined the
attern of expression of activated MAPK in late gastrula
stage 11.5/12) embryos injected with XFD RNA at the
ne-cell stage. Normal expression of activated MAPK in
ninjected stage 11.5/12 embryos is shown in whole mount
nd section in Figs. 4A and 4B, respectively. Injection of
FD RNA caused aberrant expression of activated MAPK as
letely surround the blastopore at mid- to late gastrula stages (A,
astrula embryo (dorsal is on the right and the animal pole is up).
pm) and posterior neural tissue (pn) but expression is lost in the
ue (b, brain). During neurula stages (posterior staining of stage 17
to posterior as well as anterior regions of the embryos. (C and D)
ugh the midline of the embryo, posterior staining was specifically
(D). Scale bar, 300 mm.omp
late g
rm (
tiss
lized
throell as mild exogastrulation (note the larger blastopore in
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49MAP Kinase in Early Xenopus DevelopmentFig. 4C compared to Fig. 4A) (Amaya et al., 1991). Sections
through regions affected by XFD RNA injection in stage
11.5/12 embryos showed that expression of activated
MAPK in both posterior mesoderm and neural tissue was
diminished (arrowhead in Fig. 4C; arrows in Fig. 4D). This
suggests that at least some early expression of activated
MAPK in the posterior mesoderm and neural tissue of late
gastrulae depends on FGF signaling.
We also examined the effect of XFD RNA injection on
expression of activated MAPK and Xbra on posterior meso-
dermal and neural tissue in midneurula stage embryos
(stage 15/16). In some cases embryos were co-injected with
XFD and b-gal RNA to confirm where XFD was expressed.
Xbra expression was also followed in order to monitor the
effectiveness of the XFD RNA in blocking FGF signaling.
Normal expression of activated MAPK is shown in Figs. 4E
(whole mount) and 4F (section). We observed a reduced
amount of activated MAPK expression in all embryos
(31/31) injected with XFD [Figs. 4G (whole mount) and 4H
(section)]. Normal expression of Xbra is shown in Figs. 4I
(whole mount) and 4J (section). As expected, expression of
Xbra was also reduced in most (19/21) stage 15/16 embryos
(arrow in Fig. 4K). Xbra and activated MAPK were found in
tail-like protrusions in the posterior of stage 15/16 embryos
(Figs. 4G and 4K, arrowheads) that may represent tissue in
which some posterior mesoderm was formed. b-Gal stain-
ng in these embryos was reduced or undetectable in the
ail-like protrusions of whole-mount preparations (data not
hown). Areas that did not form a tail did not express Xbra
r activated MAPK (Figs. 4G and 4K, arrows) and also
isplayed strong b-gal staining (data not shown). The “tails”
appear to represent areas with decreased expression of the
XFD protein since b-gal staining is decreased or absent.
Also, Xbra is present in the mesoderm of such structures
(arrowhead in Fig. 4K; arrow in Fig. 4L), which indicates the
presence of active FGF signaling. Sections through embryos
FIG. 4. Activated MAPK expression is affected in the posterior me
(A–D) Dorsal is up. A and B show activated MAPK around the blast
respectively. The arrowhead in A points to the approximate regio
posterior neural (pn) tissue. C and D show expression of activated
section, respectively. The arrowhead in C shows the approximate re
of the pn and the absence of activated MAPK. (E–L) Anterior is to
expression of activated MAPK in a stage 15/16 embryo from a do
expression of activated MAPK. F shows a sagittal section of a st
activated MAPK in the posterior mesoderm (m) and neural (n) tissu
arrowhead denotes the presence of activated MAPK in a “tail-like
posterior which does not form a tail. H shows a sagittal section of th
the expression of activated MAPK in a tail-like protrusion. Note th
while the levels of activated MAPK in neural tissue is less affected.
he neural tissue. Colocalization of activated MAPK and b-gal is ma
of the normal in situ hybridization pattern for Xbra in an unclear
extent of Xbra staining (not including the notochord which is not
blastopore region (arrows). K shows a dorsal view of Xbra expressi
expression of Xbra in a tail-like protrusion, while the arrow denote
a tail. L shows a sagittal section of a tail-like protrusion expressing Xb
Copyright © 2000 by Academic Press. All rightstained for both b-gal and activated MAPK (Fig. 4H) show
osaic expression of b-gal in both the posterior mesoderm
(m) and neural tissue (n) of tail-like structures. When
viewed in section, activated MAPK in the mesoderm of
these tails ranged from low to undetectable levels (Fig. 4H,
m), while the levels of activated MAPK in the posterior
neural tissue were less affected (Fig. 4H, n). The inset (Fig.
4H) illustrates colocalization of b-gal (XFD) and activated
MAPK in a posterior neural cell (arrowhead). The low to
undetectable levels of activated MAPK in the posterior
mesoderm and relatively higher levels of activated MAPK
in the posterior neural tissue were seen frequently. The
mosaic expression of b-gal in the posterior mesoderm and
eural tissue suggested that FGF signaling was only par-
ially blocked in the “tail-like” structures. Further evidence
or at least low levels of FGF signaling in tails was the
resence of Xbra in similar structures (Fig. 4L). This result
lso suggests that FGF signaling, while required in the
osterior mesoderm, may not be required in the posterior
eural tissue since the level of activated MAPK found there
as less affected by a decrease in FGF signaling.
In order to test more stringently whether FGF signaling in
he posterior neural ectoderm was required for posterior
eural patterning of the tissue, recombinants were made
ith lineage-labeled dorsal mesoderm (stage 11.5–12) and
arly gastrula animal caps (stage 10.25–10.5) injected with 4
g of XFD RNA. In this way FGF signaling is inhibited only
n the prospective neural tissue, permitting us to distin-
uish between the requirements of FGF signaling in meso-
erm formation and neural induction. The recombinants
ere made and aged to stage 26–28 as previously outlined
y Saha and Grainger (1992). They were then assayed for
xpression of the posterior neural marker HoxB9 by in situ
hybridization (Wright et al., 1990). The expression pattern
of HoxB9 at stage 26–28 is shown in Fig. 5A (between
arrowheads). No difference was observed in the induction of
rm of XFD-injected embryos, but not in the posterior neural tissue.
in stage 11.5/12 uninjected embryos in whole mount and section,
tured in B. The arrow in B points to activated MAPK present in
K in XFD-expressing stage 11.5/12 embryos in whole mount and
of section in D. The arrows in D indicate the approximate position
ight and dorsal is up unless otherwise noted. E shows the normal
iew. The arrowheads denote the anterior–posterior extent of the
5/16 embryo stained for activated MAPK. Note the presence of
shows a dorsal view of a stage 15/16 embryo expressing XFD. The
trusion. The arrow shows the absence of activated MAPK in the
terior of a stage 15/16 embryo expressing XFD and b-gal, displaying
ression of activated MAPK in the mesoderm is decreased or absent
ic expression of b-gal was also observed in both the mesoderm and
ed in the inset (arrowhead). n is less affected. I shows a dorsal view
age 15/16 embryo. The arrowheads denote the anterior–posterior
n). J shows a sagittal section of Xbra expression in the posterior
a stage 15/16 embryo expressing XFD. The arrowhead shows the
lack of Xbra expression in the posterior of the embryo not formingsode
opore
n pic
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s thera in the posterior mesoderm (arrow). Scale bar, 150 mm.
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51MAP Kinase in Early Xenopus DevelopmentHoxB9 RNA between uninjected (91% positive; Fig. 5B,
Table 3) and XFD-expressing (95% positive; Fig. 5C,
Table 3) animal caps. Expression of HoxB9 was charac-
terized as condensed (Figs. 5B and 5C, arrowhead; Table
3), diffuse (Figs. 5B and 5C, arrow; Table 3), or absent.
Neither uninjected nor XFD-injected animal caps alone
expressed HoxB9 (Fig. 5D, Table 3). The expression of
HoxB9 was found in the ectodermal component of recom-
binants and not in the lineage-labeled dorsal mesoderm of
both controls (arrowheads in Figs. 5E and 5F) and recom-
binants containing XFD-injected ectoderm (arrowheads
in Figs. 5G and 5H).
These results further indicate that FGF signaling may not
be required for induction of posterior neural tissues. To get
a better view of the requirements for FGF-signaling, similar
recombinants were made and assayed for activated MAPK.
As in the previous experiment, stage 10.25/10.5 sensorial
ectoderm expressing XFD or XFD and b-gal RNA was
ecombined with lineage-labeled stage 11.5/12 dorsal me-
oderm. These recombinants were cultured to the midgas-
TABLE 3
Effect of Dominant Negative FGF Receptor (XFD) RNA on the Ind
Condensed expre
Ectoderm 1 dorsal mesoderm 10
XFD-expressing ectoderm 1 dorsal mesoderm 7
Untreated ectoderm 0
Note. In these experiments, stage 10.25/10.5 animal cap ec
recombinants and control ectodermal tissues were cultured until
Condensed expression of HoxB9 refers to strong staining of HoxB
lighter staining of HoxB9 that was seen throughout the ectode
expression of HoxB9. The untreated ectoderm category includes urula stage (stage 12) when strong activation of MAPK is u
xpressing XFD. Scale bar, 150 mm.
Copyright © 2000 by Academic Press. All rightrst seen in the posterior neural tissue of whole embryos
Fig. 3B). Ectoderm of both control (80%) and XFD-
xpressing (88%) recombinants showed activation of
APK. This result can be seen in controls by comparing
rrows in bright-field (Fig. 6A) and fluorescent images (Fig.
B) and in XFD-expressing recombinants in Figs. 6C and
D. The data are summarized in Table 4. Low levels of
ctivated MAPK were also observed in the dorsal mesoderm
f both control and experimental recombinants (arrowheads
n Figs. 6A and 6B, 6C and 6D), which was expected since
ctivated MAPK is present in posterior mesoderm at these
tages. Ectoderm obtained from embryos expressing both
FD and b-gal were also analyzed. The expressions of b-gal
nd activated MAPK were shown to be colocalized in all
ases, which indicated that activation of MAPK could occur
n posterior neural cells expressing XFD (Fig. 6E, arrow).
lthough expression of activated MAPK was observed in
ecombinants containing either uninjected (control) ecto-
erm or XFD-expressing ectoderm, significantly more of the
ecombinants (P 5 0.02 by Fisher’s exact test) made with
n of HoxB9 RNA in Recombinants
HoxB9 RNA expression
Total positiveDiffuse expression Expression not detected
22 3 32/35 (91%)
30 2 37/39 (95%)
0 20 0/20 (0%)
m was recombined with stage 11.5/12 dorsal mesoderm. All
e 27 and assayed for HoxB9 expression by in situ hybridization.
alized in one part of the ectoderm. Diffuse expression refers to a
xpression not detected refers to ectoderm with no discernable
cted ectoderm as well as XFD-expressing ectoderm.uctio
ssion
toder
stag
9 loc
rm. Eninjected ectoderm showed a high level (62%) of activatedFIG. 5. Induction of HoxB9 RNA by dorsal mesoderm was not affected in animal caps expressing XFD. HoxB9 is present in the posterior
neural tube of a stage 26 embryo by whole-mount in situ hybridization (between arrowheads in A). Some background staining was observed
in the head. (B) Expression of HoxB9 in uninjected ectoderm recombined with dorsal mesoderm (arrowhead denotes condensed staining and
arrow denotes diffuse staining). (C) Expression of HoxB9 RNA in XFD-expressing ectoderm recombined with dorsal mesoderm (arrowhead
denotes condensed staining and arrow denotes diffuse staining). HoxB9 expression was not seen in untreated animal caps as seen in D
section). (E and F) The expression of HoxB9 (E, arrowhead) is not found in the RLDX-labeled dorsal mesoderm (F, arrowhead). (G) HoxB9
s present in the ectoderm (G, arrowhead) and not in the RLDX-labeled mesoderm (H, arrowhead). Scale bar, 150 mm.
IG. 6. Activation of MAPK by dorsal mesoderm was not affected in sensorial ectoderm of the animal caps injected with XFD. Stage
0.25–10.5 uninjected ectoderm recombined with stage 11.5/12 lineage-labeled dorsal mesoderm showed strong activation of MAPK as seen
n A (arrow). (A and B) Expression of activated MAPK in the ectoderm (arrow) although some activated MAPK was found in the
LDX-labeled mesoderm (arrowhead). Similar activation of MAPK was observed in recombinants made with ectoderm expressing XFD (C,
rrows). (C and D) Expression of activated MAPK in the ectoderm (arrows), while some activated MAPK was present in the RLDX-labeled
esoderm (arrowhead). (E) Activated MAPK expression (arrow) in ectoderm expressing XFD and b-gal recombined with dorsal mesoderm.
F) Strong activation of MAPK in uninjected ectoderm treated with FGF. (G) Activated MAPK expression in stage 12 XFD-expressing
ctoderm treated with FGF was found to be mosaic (arrow) or not detectable. (H) Absence of activated MAPK in untreated stage 12 ectoderms of reproduction in any form reserved.
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52 Curran and GraingerMAPK in response to induction by the dorsal mesoderm
compared to those expressing XFD (37.5%) (Table 4).
The relatively small difference between MAPK activity
in XFD-expressing and control ectoderm further indicates
that activated MAPK in these recombinants is not due to
FGF signaling, but implicates other RTK signaling path-
ways that utilize MAPK. The validity of this suggestion
depends, however, on the efficacy of the XFD treatments in
this experiment. To gauge the effectiveness of XFD injec-
tion in this experiment, we cultured XFD-expressing and
uninjected stage 10.25/10.5 sensorial ectoderm with 50
ng/ml FGF to see if FGF alone could induce activation of
MAPK at stage 12. The assays were done at this stage to
allow us to evaluate whether XFD is still being expressed at
levels that would significantly inhibit FGF signaling and for
purposes of comparison with the previous experiment.
Uninjected ectoderm responds, as expected, to FGF (Fig. 6F;
Table 4) while XFD-expressing ectoderm showed either
reduced (83%) or no expression (17%) of activated MAPK
(Fig. 6G; Table 4). Untreated ectoderm showed no activated
MAPK (Fig. 6H; Table 4).
While there is little effect of XFD on activated MAPK
levels in ectoderm responding to dorsal mesoderm, this
treatment greatly reduces the level of activated MAPK in
ectoderm when it is exposed to FGF. We conclude from the
above results that under the condition of significant inhi-
bition of FGF signaling, ectoderm can still activate MAPK
and the posterior neural marker HoxB9. These data are
consistent with the proposal that FGF signaling is not
required for posterior neural patterning during develop-
ment.
DISCUSSION
In this paper we have analyzed the activation of MAPK in
situ in order to further characterize the involvement of FGF
TABLE 4
Effect of Dominant Negative FGF Receptor (XFD) RNA Injection o
11
Ectoderm 1 dorsal mesoderm 16
XFD-expressing ectoderm 1 dorsal mesoderm 9
ctoderm 1 FGF 7
FD-expressing ectoderm 1 FGF 0
ntreated ectoderm 0
ntreated XFD-expressing ectoderm 0
Note. In these experiments, stage 10.25–10.5 sensorial ectoderm
g/ml FGF, or cultured without further treatment. All ectoderm w
mmunostaining. 11 indicates strong positive expression, 1 indica
fewer than 20% positive cells (mosaic), and 2 indicates expressiand other RTK signal transduction pathways during early d
Copyright © 2000 by Academic Press. All rightenopus embryonic development. We have described a
ytoplasmic to nuclear transition of activated MAPK in the
nimal cap and marginal zone during morula and blastula
tages. Prior to gastrulation we see an increase in the level
f MAPK activation where the future dorsal lip will form.
his increase of activation of MAPK was observed to
ncircle the blastopore as gastrulation progresses and could
e ablated by inhibition of FGF signaling. Finally, we
ddressed the patterning of the posterior mesodermal and
eural tissues during late gastrula and neurula stages and
ound that FGF signaling was not necessary for the expres-
ion of HoxB9 or activation of MAPK in posterior neural
issue.
Expression of Activated MAPK during Blastula
Stages Provides Additional Evidence for the Role of
FGF in the Regulation of Mesodermal Competence
It has been proposed that low levels of FGF signaling
occur in the animal cap and marginal zone of cleavage stage
Xenopus embryos which acts to enable these tissues to
respond to mesoderm induction by the vegetal pole (Cornell
et al., 1995; Slack, 1996; Isaacs, 1997). Thus, FGF has been
termed a “competence” factor. MAPK activation in blastula
stage embryos is of interest because of the known expres-
sion patterns of eFGF, FGF-2, and FGF-9 in the animal cap
and marginal zone (reviewed by Slack et al., 1996; Isaacs,
1997). Graves et al. (1991) also observed low levels of
ndogenous MAPK activity in animal caps during early
lastula stages. The low level of activation of MAPK that
e see in the animal cap and marginal zone demonstrates
hat FGF signaling does take place in these regions of the
mbryo and substantiates the proposal that such signaling
nfluences the responsiveness of those tissues to mesoder-
al induction.
The translocation from a predominantly cytoplasmic to a
uclear accumulation of activated MAPK that we observe
tivation of MAPK in Animal Cap Sensorial Ectoderm
Activation of MAPK
Total positive1 1/2 2
5 0 5 21/25 (81%)
12 0 3 21/24 (88%)
10 0 0 17/17 (100%)
0 10 2 0/12 (0%)
0 0 15 0/15 (0%)
0 0 9 0/9 (0%)
recombined with stage 11.5/12 dorsal mesoderm, treated with 50
ged to stage 12 and assayed for activated MAPK by whole-mount
ositive expression, 1/2 indicates mostly negative expression with
t detected.n Ac
was
as a
tes puring morula and early blastula stages is coincident with
s of reproduction in any form reserved.
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53MAP Kinase in Early Xenopus Developmentthe onset of the broader property of mesodermal compe-
tence as defined by biological assays of this process. Jones
and Woodland (1987) have shown that the ability of an
animal cap to respond to an endogenous mesodermal-
inducing tissue begins at around stage 6.5. We first see
activated MAPK predominantly in the cytoplasm at stage 6
while at stage 7 it becomes concentrated in the nuclei. This
phenomenon does not appear to have been detected by
Christen and Slack (1999) using the same antibody. It is
possible that the transition from a predominantly cytoplas-
mic to a nuclear localization may be an indicator of the
onset of mesodermal competence. It is also possible that the
subcellular localization of activated MAPK is part of the
actual “switch” which, once turned on by a putative
developmental timer, will allow activated MAPK to acti-
vate the FGF signaling pathway as required to respond to
mesodermal induction. In Drosophila, Kumar et al. (1998)
noted that a similar phenomenon occurs in the EGFR-
dependent and Sevenless-dependent activation of MAPK in
which activated MAPK is observed only in the cytoplasm
for 2 and 6 hours, respectively, before translocation to the
nucleus. Their results and ours may suggest that an addi-
tional regulated step is present in these RTK pathways.
It would be interesting to examine in more detail the role
of subcellular localization of MAPK at the onset of meso-
dermal competence. One could test whether overexpressing
the activated form of MAPK (such as the thiophosphory-
lated MAPK protein; LaBonne et al., 1995) could influence
ts subcellular localization in the animal cap and marginal
one at stage 6 and, if so, affect the onset of mesodermal
ompetence and FGF responsiveness in such embryos. Also,
he exact mechanism used for translocation of activated
APK from the cytoplasm to the nucleus is not well
nderstood. The clear temporal separation of activation and
ranslocation found during these early stages of develop-
ent may be very helpful in the elucidation of the mecha-
ism of translocation.
Expression of Activated MAPK during
Gastrulation Underscores the Importance of FGF
Signaling in Dorsal Mesoderm Formation
We first observed an increase in the level of activated
MAPK in the dorsal marginal zone of late blastula embryos
just prior to dorsal lip formation which later spreads around
the entire blastopore as gastrulation continues (Figs. 2 and
3; the later expression was also observed by Christen and
Slack, 1999). Using an assay for functional MAPK activity,
LaBonne and Whitman (1997) reported similarly that
MAPK activity is severalfold higher in the dorsal side of the
embryo from stage 9.5 to 101, preceding dorsal lip forma-
tion. Smith et al. (1991) have shown that Xbra expression
also increases between stage 9 and 10, although one cannot
say at this point which event occurs first, the activation of
MAPK or the expression of Xbra. Schulte-Merker and
mith (1995) provide evidence that Xbra can be induced butnot maintained by activin in ectoderm in which FGF
Copyright © 2000 by Academic Press. All rightignaling has been inhibited. However, Lemaire and Gur-
on (1994) were unable to induce Xbra in dispersed ecto-
ermal cells that as a consequence would have had de-
reased amounts of FGF signaling.
The loss of expression of activated MAPK in postinvolu-
ion mesoderm may indicate that a specific downregulation
f FGF signaling is required for full differentiation of
articular mesodermal fates. We observed that activated
APK expression is lost after the tissue passes over the
lastopore lip during involution, though it is maintained in
he developing notochord. Again, eFGF and Xbra have been
hown to have similar expressions (Isaacs et al., 1995). Itoh
t al. (1996) found that cells overexpressing FGFR1 could
ot differentiate into myoblasts and concluded that FGF
ignaling can block the differentiation of those cells into
uscle. Thus, the downregulation of activated MAPK (and
GF signaling) in more lateral and anterior mesoderm
ollowing involution may be necessary for further mesoder-
al differentiation to proceed. This explanation is also
onsistent with the evidence for the role of FGF in the
aintenance of Xbra expression. A downregulation of FGF
ignaling following the involution of the anterior meso-
erm would eliminate Xbra in that tissue as well. It is not
lear how FGF signaling is maintained in some mesoderm
nd not in others.
FGF Signaling Is Not Required for the Patterning
of Posterior Neural Tissue
The pattern of activated MAPK in the posterior neural
tissue during gastrula and neurula stages indicates that
some RTK signaling pathway, or pathways, plays a role in
the anterior–posterior patterning of these tissues. We found
that activated MAPK was present in the entire posterior
neural plate of neurula stage embryos (Fig. 4E). This tissue
is underlain by mesoderm expressing activated MAPK and
Xbra (notochord) and by mesoderm not expressing activated
MAPK and Xbra (somites). Absence of activated MAPK in
the somites, together with evidence indicating little or no
FGF signaling in this tissue (reviewed by Isaacs, 1997),
suggests that active FGF signaling is not likely to be present
in that tissue. Since somites nonetheless have strong
neural-inducing ability (Jones and Woodland, 1989; Barnett
et al., 1998), molecules other than FGFs in the mesoderm
are likely to play a role in the posteriorization of the neural
tissue hypothesized in the two-signal model of Nieuwkoop
(1952). This putative signal, which is proposed to be of
mesodermal origin, is argued to be responsible for posteri-
orization of anterior neural tissue.
Our results further test the role of FGF and other RTKs in
posterior neural development and are consistent with a
number of, though not all, published studies addressing the
role of FGFs in posterior neural regionalization. The experi-
ments presented here, indicating that FGF signaling is not
required for posterior neural patterning, extend the conclu-
sions reached by Kroll and Amaya (1996) and Harland
(1997). Pownall et al. (1998) and Barnett et al. (1998)
s of reproduction in any form reserved.
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54 Curran and Graingerdescribe results suggesting that the inhibition of FGF sig-
naling partially inhibits HoxB9 expression. Differences in
staging of embryos and experimental manipulation may
account for the differences between our results. Our con-
clusion that much of the activated MAPK activity in
posterior neural tissue is indicative of non-FGF signaling
pathways is also consistent with the findings of Uzgare et
l. (1998). These authors showed that there was no quanti-
ative change in the levels of MAPK activity in response to
GF in posterior neural tissue, suggesting that FGF was not
equired for the MAPK activity they observed.
One study, that of Holowacz and Sokol (1999), reports
xperiments similar to our recombinants testing whether
nhibition of FGF signaling can block posterior neural
nduction, but reaches a different conclusion: that FGF
ignaling is required for posterior neural patterning. These
uthors did not detect HoxB9 in XFD-expressing ectoderm
when it was recombined with dorsal mesoderm, using
experimental conditions similar to our own. In their experi-
ments, Holowacz and Sokol (1999) used a different injection
regime to target high levels of XFD to the ectoderm in their
recombinants. It is possible that these higher levels of XFD
may inhibit other FGFR family members that are only
partially inhibited in our experiments. However, one must
then explain the expression of activated MAPK in posterior
neural tissue that is underlain by somites not expressing
activated MAPK. If ectoderm expressing activated MAPK
overlying the nonexpressing mesoderm were responding to
an FGF signal, it must have arisen from within the ecto-
derm itself or conceivably from a cryptic FGF signal arising
in the mesoderm but not active there. One other difference
between the Holowacz and Sokol (1999) protocol and our
own is that they isolated dorsal mesoderm using both a low
calcium/magnesium medium and collagenase, while we did
not. The differences in our procedures could affect signals
that become associated with the extracellular matrix. The
possibility then exists that the posteriorizing signal or
signals arising from the dorsal mesoderm may be different
under the different conditions used in our experiments.
Our results may indicate that FGF, although not neces-
sary, may nonetheless play some role in the posterior neural
tissue. We did find a statistically significant decrease in the
level of activated MAPK in recombinants made with XFD-
expressing ectoderm (Table 4). We know that FGF is suffi-
cient to posteriorize an anterior neural fate since animal cap
ectoderm treated with neuralizing agents such as noggin,
follistatin, or a dominant negative activin receptor can
express posterior neural markers (such as HoxB9) only in
the presence of FGF (Lamb and Harland, 1995; Cox and
Hemmati-Brivanlou, 1995; reviewed by Doniach, 1995). It
is interesting to note that the expression of activated MAPK
does overlap with many of the reported expression patterns
of FGF (data not shown and Christian and Slack, 1999). Yet,
as discussed earlier, we find that activated MAPK expressed
in the posterior neural tissue is present laterally, above
tissue that may not have a functional FGF signaling system.
It is possible then to propose that a midline FGF-signaling
Copyright © 2000 by Academic Press. All rightsystem may influence the posteriorization of neural tissue,
but that another RTK signaling system, located in somites
and possibly midline mesodermal tissues as well, contrib-
utes significantly to posterior neural patterning.
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